ALSPW Fundamental Analysis - SPINEWAY

Name: SPINEWAY (ALSPW) Stock
Brand: SPINEWAY
Rating: 6 (3 reviews)

Fundamental Rating

ALSPW gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. ALSPW scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ALSPW is valied quite expensively at the moment, while it does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALSPW had negative earnings in the past year.

ALSPW had a positive operating cash flow in the past year.

ALSPW had negative earnings in each of the past 5 years.

In the past 5 years ALSPW always reported negative operating cash flow.

1.2 Ratios

ALSPW has a worse Return On Assets (-6.29%) than 68.33% of its industry peers.

The Return On Equity of ALSPW (-7.96%) is worse than 66.67% of its industry peers.

		Industry Rank	Sector Rank
ROA	-6.29%
ROE	-7.96%
ROIC	N/A

ROA(3y)-16.26%

ROA(5y)-30.05%

ROE(3y)-21.45%

ROE(5y)-42.44%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 71.33%, ALSPW belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.

In the last couple of years the Gross Margin of ALSPW has grown nicely.

The Profit Margin and Operating Margin are not available for ALSPW so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	71.33%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.32%

GM growth 5Y16.07%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALSPW does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for ALSPW has been increased compared to 1 year ago.

Compared to 5 years ago, ALSPW has more shares outstanding

ALSPW has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of 1.39, we must say that ALSPW is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 1.39, ALSPW is not doing good in the industry: 66.67% of the companies in the same industry are doing better.

ALSPW has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.

ALSPW's Debt to Equity ratio of 0.06 is amongst the best of the industry. ALSPW outperforms 81.67% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	N/A
Altman-Z	1.39

ROIC/WACCN/A

WACC6.96%

2.3 Liquidity

ALSPW has a Current Ratio of 3.19. This indicates that ALSPW is financially healthy and has no problem in meeting its short term obligations.

ALSPW's Current ratio of 3.19 is amongst the best of the industry. ALSPW outperforms 86.67% of its industry peers.

A Quick Ratio of 2.04 indicates that ALSPW has no problem at all paying its short term obligations.

ALSPW has a better Quick ratio (2.04) than 78.33% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.19
Quick Ratio	2.04

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ALSPW shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 99.85%, which is quite impressive.

Looking at the last year, ALSPW shows a decrease in Revenue. The Revenue has decreased by -5.46% in the last year.

The Revenue has been growing by 18.95% on average over the past years. This is quite good.

EPS 1Y (TTM)99.85%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%95.92%

Revenue 1Y (TTM)-5.46%

Revenue growth 3Y40.7%

Revenue growth 5Y18.95%

Sales Q2Q%-14.72%

3.2 Future

The Earnings Per Share is expected to decrease by -41.47% on average over the next years. This is quite bad

Based on estimates for the next years, ALSPW will show a very strong growth in Revenue. The Revenue will grow by 40.08% on average per year.

EPS Next Y-100.14%

EPS Next 2Y-41.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2Y40.08%

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALSPW. In the last year negative earnings were reported.

Also next year ALSPW is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

100.00% of the companies in the same industry are more expensive than ALSPW, based on the Enterprise Value to EBITDA ratio.

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	2.78

4.3 Compensation for Growth

ALSPW's earnings are expected to decrease with -41.47% in the coming years. This may justify a cheaper valuation.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y-41.47%

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALSPW!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

SPINEWAY

EPA:ALSPW (11/6/2025, 7:00:00 PM)

0.1582

-0.01 (-8.02%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)10-14 2025-10-14

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap5.62M

Revenue(TTM)10.99M

Net Income(TTM)-1.90M

Analysts86.67

Price Target0.28 (76.99%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DP0%

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)-25%

PT rev (3m)-22.86%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)-800%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.51
P/FCF	N/A
P/OCF	9.68
P/B	0.24
P/tB	0.39
EV/EBITDA	2.78

EPS(TTM)-0.05

EYN/A

EPS(NY)-0.09

Fwd EYN/A

FCF(TTM)-0.02

FCFYN/A

OCF(TTM)0.02

OCFY10.33%

SpS0.31

BVpS0.67

TBVpS0.41

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-6.29%
ROE	-7.96%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	71.33%
FCFM	N/A

ROA(3y)-16.26%

ROA(5y)-30.05%

ROE(3y)-21.45%

ROE(5y)-42.44%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-4.32%

GM growth 5Y16.07%

F-Score6

Asset Turnover0.36

Health

		Industry Rank	Sector Rank
Debt/Equity	0.06
Debt/FCF	N/A
Debt/EBITDA	1.36
Cap/Depr	118.69%
Cap/Sales	12.83%
Interest Coverage	N/A
Cash Conversion	51.42%
Profit Quality	N/A
Current Ratio	3.19
Quick Ratio	2.04
Altman-Z	1.39

F-Score6

WACC6.96%

ROIC/WACCN/A

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)N/A

Cap/Sales(5y)N/A

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)99.85%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%95.92%

EPS Next Y-100.14%

EPS Next 2Y-41.47%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-5.46%

Revenue growth 3Y40.7%

Revenue growth 5Y18.95%

Sales Q2Q%-14.72%

Revenue Next YearN/A

Revenue Next 2Y40.08%

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y97.91%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y94.45%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y121.03%

OCF growth 3YN/A

OCF growth 5YN/A

SPINEWAY / ALSPW.PA FAQ

Can you provide the ChartMill fundamental rating for SPINEWAY?

ChartMill assigns a fundamental rating of 3 / 10 to ALSPW.PA.

What is the valuation status for ALSPW stock?

ChartMill assigns a valuation rating of 1 / 10 to SPINEWAY (ALSPW.PA). This can be considered as Overvalued.

What is the profitability of ALSPW stock?

SPINEWAY (ALSPW.PA) has a profitability rating of 2 / 10.

What is the earnings growth outlook for SPINEWAY?

The Earnings per Share (EPS) of SPINEWAY (ALSPW.PA) is expected to decline by -100.14% in the next year.

Can you provide the dividend sustainability for ALSPW stock?

The dividend rating of SPINEWAY (ALSPW.PA) is 0 / 10 and the dividend payout ratio is 0%.

SPINEWAY (ALSPW.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SPINEWAY / ALSPW.PA FAQ

Can you provide the ChartMill fundamental rating for SPINEWAY?

What is the valuation status for ALSPW stock?

What is the profitability of ALSPW stock?

What is the earnings growth outlook for SPINEWAY?

Can you provide the dividend sustainability for ALSPW stock?